<DOC>
	<DOCNO>NCT02732457</DOCNO>
	<brief_summary>The purpose study assess impact allogeneic hematopoietic stem cell transplantation ( HSCT ) HIV infect patient persistence HIV HIV immune response .</brief_summary>
	<brief_title>Allogeneic Hematopoietic Stem Cell Transplantation HIV-1 Infected Patients</brief_title>
	<detailed_description>1 . To assess impact HSCT immune response HIV measuring HIV specific antigens peripheral blood ( via immune assay ELISA Western blot ) longitudinally . 2 . To measure decay persist HIV sequence quantitating HIV RNA plasma , HIV DNA RNA peripheral blood cell include CD4+ T cell CD4+ T cell subset , well tissue cell derive fine needle lymph node aspirate , and/or bone marrow aspirate , and/or rectal tissue . 3 . To determine presence CCR5 delta 32 allele patient prior follow HSCT provide information regard presence gene donor cell . 4 . To correlate finding clinical outcome individual enrol study base clinical standard care assessment follow HSCT .</detailed_description>
	<criteria>HIV1 infection , require allogeneic , haematopoietic SCT determine treat Physician ( Haematologist ) . Over 18 year age Provision write , informed consent In opinion investigator patient able provide inform consent Hb &lt; 9 ( g/dL ) CD4+ T cell count &lt; 100 ( cells/Âµl ) Serious coagulation abnormality , platelet count &lt; 50 . Patients currently take medication significantly affect bleed time ( e.g . warfarine , clexane , FXa antagonists ) History allergy local anaesthetic Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Persistence</keyword>
	<keyword>Reservoirs</keyword>
	<keyword>Stem Cell Transplant</keyword>
	<keyword>Functional Cure</keyword>
</DOC>